Literature DB >> 9420879

Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance.

M P Diamond1, K Thornton, M Connolly-Diamond, R S Sherwin, R A DeFronzo.   

Abstract

OBJECTIVE: Maintenance of normal glucose tolerance is achieved in subjects with a wide range of insulin sensitivity. It follows, therefore, that the body must possess a sensor mechanism that assesses the body's sensitivity to insulin and appropriately adjusts the secretion of insulin to maintain normal glucose homeostasis. We evaluated the relation between insulin action and insulin secretion.
METHODS: Euglycemic hyperinsulinemic clamp (1 mU/kg.minute) and hyperglycemic clamp (+125 mg/dL) studies were performed in 32 non-obese women with normal oral glucose tolerance tests. The subjects were stratified into quartiles based upon their insulin-mediated rate of glucose uptake during the euglycemic insulin clamp.
RESULTS: Total body glucose disposal varied threefold, ranging from 4.00 to 11.18 mg/kg.minute. A significant inverse relation (r = -0.50, P < .01) was noted between the rate of total body insulin-mediated glucose disposal (insulin clamp) and the total plasma insulin response during the hyperglycemic clamp. Women in the lowest quartile of insulin sensitivity (mean glucose uptake 5.07 +/- 0.20 mg/kg.minute) had the highest plasma insulin response during the hyperglycemic clamp (109 +/- 20 microU/mL). In contrast, women in the highest quartile of insulin sensitivity (glucose uptake 9.90 +/- 0.38 mg/kg.minute) had the lowest plasma insulin response during the hyperglycemic clamp (55 +/- 16 microU/mL; P < .001 versus the lowest quartile).
CONCLUSIONS: These results demonstrate that among subjects with normal glucose tolerance, there exists a large variation in both insulin-mediated glucose uptake and pancreatic insulin secretion. Nonetheless, normal glucose tolerance is maintained because of a finely regulated balance, which couples the demand for insulin secretion by the pancreatic beta cells to the level of whole-body insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9420879     DOI: 10.1016/1071-5576(95)00023-8

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  13 in total

1.  A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.

Authors:  Kirstin F Barnhart; Dawn R Christianson; Patrick W Hanley; Wouter H P Driessen; Bruce J Bernacky; Wallace B Baze; Sijin Wen; Mei Tian; Jingfei Ma; Mikhail G Kolonin; Pradip K Saha; Kim-Anh Do; James F Hulvat; Juri G Gelovani; Lawrence Chan; Wadih Arap; Renata Pasqualini
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

Review 2.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

3.  Insulin resistance: Is it time for primary prevention?

Authors:  Valentina Mercurio; Guido Carlomagno; Valeria Fazio; Serafino Fazio
Journal:  World J Cardiol       Date:  2012-01-26

Review 4.  Metabolic and molecular basis of insulin resistance.

Authors:  Mandeep Bajaj; Ralph A Defronzo
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

5.  Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose.

Authors:  Muhammad Abdul-Ghani; Hussein Al Jobori; Giuseppe Daniele; John Adams; Eugenio Cersosimo; Curtis Triplitt; Ralph A DeFronzo
Journal:  Diabetes       Date:  2017-06-13       Impact factor: 9.461

6.  Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.

Authors:  Diedre Winner; Luke Norton; Mustafa Kanat; Ruth Arya; Marcel Fourcaudot; Andrea Hansis-Diarte; Devjit Tripathy; Ralph A DeFronzo; Christopher P Jenkinson; Muhammad Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2014-05-05       Impact factor: 5.958

7.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

Authors:  A Gastaldelli; E Ferrannini; Y Miyazaki; M Matsuda; R A DeFronzo
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

8.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

9.  Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.

Authors:  Ralph A DeFronzo; Roy Eldor; Muhammad Abdul-Ghani
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 10.  Plasma glucose concentration and prediction of future risk of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.